End-of-day quote
Shanghai S.E.
18:00:00 2024-05-09 EDT
|
5-day change
|
1st Jan Change
|
18.3
CNY
|
-2.35%
|
|
+4.57%
|
-35.70%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
6,660
|
3,783
|
3,506
|
2,255
|
-
|
Enterprise Value (EV)
1 |
6,660
|
3,783
|
3,506
|
2,255
|
2,255
|
P/E ratio
|
68.8
x
|
91.5
x
|
-49.1
x
|
6.85
x
|
5.46
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
16,977,586
x
|
-
|
-
|
-
|
-
|
EV / Revenue
|
16,977,586
x
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
58,847,022
x
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
4.56
x
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
123,200
|
123,200
|
123,200
|
123,200
|
-
|
Reference price
2 |
54.06
|
30.71
|
28.46
|
18.30
|
18.30
|
Announcement Date
|
22-02-25
|
23-04-19
|
24-04-15
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
|
-
|
392.3
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
113.2
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
83.97
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
21.41%
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
84
|
-
|
-
|
-
|
-
|
Net income
1 |
155
|
82.46
|
41.54
|
-70.99
|
328.8
|
413
|
Net margin
|
-
|
21.02%
|
-
|
-
|
-
|
-
|
EPS
2 |
1.679
|
0.7857
|
0.3357
|
-0.5800
|
2.670
|
3.350
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-07-12
|
22-02-25
|
23-04-19
|
24-04-15
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
10.9%
|
-
|
-5.02%
|
17.7%
|
19.1%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
11.90
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
0.8400
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-07-12
|
22-02-25
|
23-04-19
|
24-04-15
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -35.70% | 320M | | -2.61% | 88.47B | | +3.55% | 40.71B | | -14.05% | 32.43B | | +55.89% | 24.28B | | -15.93% | 15.52B | | -41.29% | 12.17B | | -15.23% | 12.01B | | -11.75% | 12B | | +7.87% | 8.87B |
Biopharmaceuticals
|